
Agilent Technologies A
€ 97.59
2.38%
Quartalsbericht 2025-Q4
hinzugefügt 03.03.2026
Agilent Technologies P/CF 2011-2026 | A
P/CF Jährlich Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 28.3 | 44.9 | 29.3 | 25.5 | 31.3 | 21.9 | 35.4 | 28.1 | 13.7 | 9.22 | 8.68 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 44.9 | 8.68 | 25.1 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.25 | 0.06 % | $ 171 M | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 20.65 | -0.75 % | $ 1.1 B | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.65 | 7.84 % | $ 2.19 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 15.07 | 1.82 % | $ 456 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 24.54 | 1.24 % | $ 682 M | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 115.88 | -0.25 % | $ 9.56 B | ||
|
Illumina
ILMN
|
19.6 | $ 125.86 | 4.56 % | $ 20 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 164.61 | 0.47 % | $ 8.16 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
-72.7 | $ 84.55 | 1.37 % | $ 10.6 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 81.81 | 0.79 % | $ 5.52 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 416.27 | 0.65 % | $ 12 B | ||
|
NeoGenomics
NEO
|
284 | $ 9.11 | 1.62 % | $ 1.17 B | ||
|
National Research Corporation
NRC
|
11.9 | $ 16.4 | -0.85 % | $ 367 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 26.22 | 2.5 % | $ 20 B | ||
|
Personalis
PSNL
|
-5.62 | $ 5.16 | 2.28 % | $ 306 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.24 | -2.88 % | $ 260 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.16 | - | $ 4.96 M | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 475.17 | 1.91 % | $ 179 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 264.03 | 2.68 % | $ 22 B | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.62 | 3.33 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 58.32 | 2.86 % | $ 3.49 B | ||
|
Celcuity
CELC
|
-35 | $ 119.44 | 0.37 % | $ 5.58 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.28 | 2.94 % | $ 2.01 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.75 | 1.39 % | $ 440 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
Natera
NTRA
|
-12.3 | $ 200.62 | 3.01 % | $ 19.7 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 195.73 | 3.36 % | $ 21.7 B |